Policy | September 09, 2021
New law to regulate drugs and medical devices soon
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
Takeda is establishing the capability to manufacture TAK-019 (known outside Japan as NVX-CoV2373) at its facilities in Japan and aims to begin distribution in the early calendar year 2022
It is the first-ever approval in India for the treatment of Female Pattern Hair Loss (FPHL) and will be available only on prescription by a dermatologist
Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
PPH is associated with almost 20 per cent of maternal mortality in India
Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options
When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers
Investment of Rs 235 crores to add 411 beds in the next 18 months
The government has recently enhanced the incentive granted to storeowners from existing Rs. 2.50 lakh to Rs. 5.00 lakh given at the rate of 15% of monthly purchases made, subject to a ceiling of Rs. 15,000 per month
Subscribe To Our Newsletter & Stay Updated
